Trifluridine/tipiracil + Oxaliplatin ± Nivolumab Vs FOLFOX ± Nivolumab in HER2 Negative Advanced Oesogastric Adenocarcinoma: the PRODIGE73-UCGI40-LOGICAN Trial
Damien Botsen,Sylvie Chabaud,Herve Perrier, Hanifa Ammarguellat, Veronique Jestin-Le-Tallec, Jonathan Olesinski,Clemence Toullec,Thomas Aparicio,Meher Ben Abdelghani,Christophe Borg,Olivier Bouche,Clelia Coutzac, Herve Devaud,Frederic Di Fiore,Olivier Dubreuil,Ludovic Evesque, Bruno Huguenin,Marie Muller,Pierre-Guillaume Poureau, Emilie Oularue,David Tougeron,Aziz Zaanan,Samy Ammari,Nicolas De Sousa Carvalho,Pierre Decazes,Christelle De La Fouchardiere DIGESTIVE AND LIVER DISEASE（2024）
关键词
Advanced/metastatic gastric and,gastroesophageal junction adenocarcinomas,(2 & agrave,4): Trifluridine/tipiracil
AI 理解论文
溯源树
样例
